AUS
NZ
UK
CA
USA
IND
Highlights
- Singular Health announces partnership with Miami-based health clinic.
- Focus on advancing its 3Dicom technology through a commercial pilot.
- Partnership includes A$500,000 equity investment from Provider Network Solutions (PNS).
Singular Health (ASX:SHG) has made headlines by securing a Memorandum of Understanding (MOU) and strategic placement agreement with Miami-based Provider Network Solutions (PNS). This partnership aims to advance Singular’s innovative 3Dicom software, designed to revolutionize medical imaging by integrating MRI and CT scan datasets into 3D patient-specific anatomical views, showcasing the potential of ASX healthcare stocks in driving medical technology innovation.
The 3Dicom software, which Singular describes as being in its "early stages," operates as an app to enhance diagnostic imaging. The agreement sets the stage for a preliminary commercial pilot, marking the first practical application of the technology. If successful, the pilot is expected to lead to a broader rollout across PNS's expansive network.
PNS, a significant player in the healthcare space, manages over 3.7 million member plans in Florida. Singular highlights PNS as a leading managed specialty care provider in the state, making this collaboration a promising step forward for its technology.
As part of the partnership, PNS has invested A$500,000 in Singular Health, which the company refers to as a “cornerstone equity investment.” This contribution is part of a larger A$3.7 million capital raise conducted at 9 cents per share. The funds will be allocated towards the ongoing development of 3Dicom, the initial pilot program, and general working capital needs.
Denning Chong, CEO of Singular Health, expressed enthusiasm about the collaboration, citing the months of due diligence and discussions leading to this strategic agreement. Chong emphasized the significance of the technical proof-of-concept, which is set to begin soon, as an opportunity to strengthen the relationship with PNS and pave the way for future milestones.
The announcement has had a positive impact on Singular Health’s stock price, reflecting market confidence in the partnership's potential. With the financial support and network access provided by PNS, Singular Health is poised to explore broader applications for its cutting-edge medical imaging technology.
This strategic collaboration underscores Singular Health's commitment to innovation in healthcare and positions the company for growth as it moves toward commercializing its advanced imaging solutions.
